From Toad Venom to Drug Development: The Clinical Pharmacology of Mebufotenin (5-MeO-DMT) in Treatment-Resistant Depression

Robert Likić, Igor Radanović, Deni Rkman, Sanja Brnić, Gabriel Jacobs, Geert Jan Groeneveld

Open source

DOI: 10.1007/s40263-026-01346-0
Published: 2026-11-04
Container: CNS Drugs
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40263-026-01346-0,
  title = {From Toad Venom to Drug Development: The Clinical Pharmacology of Mebufotenin (5-MeO-DMT) in Treatment-Resistant Depression},
  author = {Robert Likić and Igor Radanović and Deni Rkman and Sanja Brnić and Gabriel Jacobs and Geert Jan Groeneveld},
  year = {2026},
  journal = {CNS Drugs},
  doi = {10.1007/s40263-026-01346-0},
  url = {https://doi.org/10.1007/s40263-026-01346-0}
}

RIS

TY  - JOUR
TI  - From Toad Venom to Drug Development: The Clinical Pharmacology of Mebufotenin (5-MeO-DMT) in Treatment-Resistant Depression
AU  - Robert Likić
AU  - Igor Radanović
AU  - Deni Rkman
AU  - Sanja Brnić
AU  - Gabriel Jacobs
AU  - Geert Jan Groeneveld
PY  - 2026
JO  - CNS Drugs
DO  - 10.1007/s40263-026-01346-0
UR  - https://doi.org/10.1007/s40263-026-01346-0
ER  -

APA

Likić, R., Radanović, I., Rkman, D., Brnić, S., Jacobs, G., & Groeneveld, G. J. (2026). From Toad Venom to Drug Development: The Clinical Pharmacology of Mebufotenin (5-MeO-DMT) in Treatment-Resistant Depression. CNS Drugs. https://doi.org/10.1007/s40263-026-01346-0

Source records

crossref · retrieved 2026-11-06T17:16:04.100Z